FOOT

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: FOOT
Generic name: MENTHOL
Manufacturer: Smith Amish, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 20c48537-f55f-c10f-e063-6394a90a4cca
SPL ID: 45c89ca7-3353-d315-e063-6394a90ac647
Version: 6
Effective date: 2025-12-12
Source export date: 2026-11-06
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 06:56:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		FOOT	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Smith Amish, LLC	openfda.manufacturer_name
ndc	package	72609-703-02	openfda.package_ndc
ndc	package	72609-703-04	openfda.package_ndc
ndc	product	72609-703	openfda.product_ndc
ndc11	package	72609070304	derived:openfda.package_ndc
ndc11	package	72609070302	derived:openfda.package_ndc
rxcui		416982	openfda.rxcui
spl id		45c89ca7-3353-d315-e063-6394a90ac647	id
spl set id		20c48537-f55f-c10f-e063-6394a90a4cca	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Avoid contact with eyes If condition worsens, or if symptoms persist for more than 7 days or cler up and occur again within a few days,, discontinue use of this product and consult a doctor. If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.